Epilepsy Guidelines for Women: What a Systematic Review Found
Researchers systematically reviewed clinical practice guidelines for women with epilepsy published in English or Korean from January 2014 through December 2024.
Pregnancy
This hub covers epilepsy and pregnancy: Seizure control, medication safety, folic acid, and planning before, during, and after pregnancy. Research summaries to support informed decisions.
What you’ll find in this topic:
- Plain-language summaries of new epilepsy studies
- What the research means for real life
- Practical questions to ask your neurologist
- Related topics you can explore next
Epilepsy and Pregnancy: What Families Usually Want to Know
- Planning before pregnancy (the best time to reduce risk)
- Medication safety, seizure control, and why abrupt changes are risky
- Folic acid and prenatal monitoring
- Postpartum: sleep deprivation, meds, and newborn safety planning
Common Pregnancy Terms in Plain English
- Teratogenic risk: chance a medication affects fetal development
- Monotherapy: one medication (often preferred when possible)
- Therapeutic drug monitoring: checking blood levels (levels can shift in pregnancy)
- Preconception counseling: planning visit before pregnancy to optimize meds and safety
- Postpartum risk: seizure risk can change due to sleep loss and hormone shifts
Related Topics
Epilepsy and Pregnancy FAQ
Should I stop my medication if I’m pregnant?
No. Stopping medication suddenly can be dangerous. Medication decisions should be planned with your neurologist/OB.
Why do medication levels change in pregnancy?
Body water, metabolism, and clearance change. Some meds need dose adjustments guided by blood levels.
Do seizures always get worse during pregnancy?
Not always. Many people remain stable, especially with good adherence and monitoring.
What about sleep after the baby arrives?
Sleep deprivation is a real risk. Planning shifts and extra support isn’t “extra,” it’s safety.
-
-
Paternal valproate exposure and child neurodevelopment: What this Taiwan study found
This nationwide Taiwan study included 2,583,503 people born from 2001 through 2016 and followed through 2021.
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | New Studies | Pediatrics | Pregnancy
Personalized Perampanel Dosing May Improve Seizure Treatment
This article discusses a proposed way to personalize dosing of perampanel, a seizure medicine used in drug-resistant epilepsy.
-
Devices & Neuromodulation | Epilepsy Research Summaries | Genetics | New Studies | Pediatrics | Pregnancy
Fathers’ Valproate Use Not Linked To Child Development Disorders
This study looked at whether children had a higher chance of neurodevelopmental disorders if their father used valproate during the 3 months before conception, which is the time period used in the study to represent spermatogenesis.
-
Lamotrigine Blood Levels Did Not Predict Seizures In Pregnancy
Researchers looked at whether repeated blood levels of lamotrigine during pregnancy were associated with seizure occurrence during pregnancy or up to 6 weeks after birth, and whether these serial measurements improved prediction of seizure risk beyond baseline clinical factors.
-
Climate Change May Worsen Children’s Brain And Nerve Conditions
This paper was a scoping review, which means the authors gathered and summarized existing research rather than running one new experiment.
-
Brain Scans And EEGs May Predict Early Epilepsy Risk
This study looked at whether early brain tests could help identify which babies might later develop epilepsy after a neonatal stroke.
-
Heart Tumors Before Birth May Signal Tuberous Sclerosis
This study looked at 80 fetuses found before birth to have one or more cardiac rhabdomyomas, which are heart tumors often linked with tuberous sclerosis complex (TSC).
-
Some Seizure Medicines In Pregnancy Linked To Lower Child IQ
This Australian semiprospective cohort study looked at whether children exposed to one antiseizure medication during pregnancy had different thinking and learning outcomes than children who were not exposed to antiseizure medicines before birth.
